emapalumab   Click here for help

GtoPdb Ligand ID: 9295

Synonyms: emapalumab-lzsg | Gamifant® | NI-0501 | NI0501
Approved drug Immunopharmacology Ligand
emapalumab is an approved drug (FDA (2018))
Compound class: Antibody
Comment: Emapalumab (NI-0501) is a fully human monoclonal antibody that targets interferon gamma (IFNγ).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide anaylsis reveals identical matches with peptides claimed in patent WO2006109191, and in which NI-0501 is confirmed as an exemplary antibody [2].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. FDA (2018)
International Nonproprietary Names Click here for help
INN number INN
10319 emapalumab
Synonyms Click here for help
emapalumab-lzsg | Gamifant® | NI-0501 | NI0501
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 666
Other databases
GtoPdb PubChem SID 318164814
Search PubMed clinical trials emapalumab
Search PubMed titles emapalumab
Search PubMed titles/abstracts emapalumab